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H1. Current literature highlights
1.1. An alpha-helix library targeting protein–protein interactions
Protein–protein interactions are ubiquitous across all biological
processes including cellular signalling. Modulation of such large
surface interactions offers novel and effective ways of disrupting
cell signalling and thus opportunities for therapeutic intervention.
However, small molecules rarely make a sufﬁcient number of bind-
ing interactions to give the level of potency required for a thera-
peutic, and thus the development of such molecules has been
very slow.
As many protein–protein interactions are mediated by the rec-
ognition of a protein a-helix structure, there has been an increas-
ing focus on making mimics of this domain. A recent publication
describes the design and synthesis of library of a-helix mimics
based on a precedented triaryl template, and the screening of this
library in the search for inhibitors of the MDM2/p53 binding
interaction.1
The a-helix is a frequently occurring protein secondary struc-
ture, and interactions of this structure are often mediated by spe-
ciﬁc presentation of the side chains on the i, i + 4 and i + 7 amino
acid residues. A number of synthetic mimics that present similarly
spaced side chains have been investigated. For the 8000 compound
library described in this publication, 400 mixtures each of 20 com-
pounds were prepared in solution, to mimic all possible permuta-
tions of naturally occurring amino acid side chains. The structures
(1) contained a non-natural aryl monomer in a central position
ﬂanked by natural amino acids at both ends. Screening the library
mixtures against MDM2/p53 revealed a preference for the Trp side
chain equivalent in the central position. Although this result repre-
sented an averaged afﬁnity across the mixtures, and might have
masked individual potent compounds with different central
residues, further investigation of active structures was achieved
by deconvolution of the other side chain positions. Individual
compound synthesis identiﬁed H2N-Phe-[Trp]-Leu-OH (2) as the
preferred inhibitor.
1.2. A ﬂuorous-tagged ‘safety-catch’ linker for library synthesis
Ring-closing metathesis, especially that using the ruthenium
complex catalysts which are highly tolerant of other functionaldoi:10.1016/j.comche.2009.05.002
E-mail: nterrett@ensemblediscovery.comgroups, has been widely used in chemistry in recent years. In par-
ticular, the mild conditions permit metathesis chemistry to be
used in the synthesis of combinatorial libraries. A recent publication
describes a novel ﬂuorous-tagged linker that can be used for the
synthesis of heterocycles prepared by ring-closing metathesis.2
The ﬂuorous tag (RF) contains a perﬂuorinated alkyl chain that
has a high afﬁnity for other perﬂuorinated materials, such that
this avidity can be used as a form of phase separation for tagged
intermediates and products. The ﬂuorous tags in this study al-
lowed separation of wanted products from other excess reagents,
by binding to a ﬂuorous solid support in the process of ﬂuorous
solid-phase extraction (F-SPE). As the product would still be ﬂuor-
ous-tagged, further chemical manipulations can be undertaken
and the same F-SPE process employed for puriﬁcation.
The ﬂuorous ‘safety-catch’ linker in this study (3) was function-
alised to generate a terminal alkene suitable as a metathesis sub-
strate (4). A cascade of metathesis and cyclisation reactions was
then undertaken, resulting in the generation of an acetal group.
26 N. K. Terrett / Combinatorial Chemistry - An Online Journal 11 (2009) 25–27The ‘safety-catch’ design then allowed selective cleavage of the
acetal 5 to release only the metathesis products from the ﬂuorous
linker.
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This approach has been used in the controlled functionalisation of a
number of glucose-derived trialkenes to give an array of stereo-
chemically controlled heterocyclic products. Overall the design of
the ﬂuorous ‘safety-catch’ linker permits easy puriﬁcation of sub-
strates, removal of the metathesis catalyst and the ﬁnal clean re-
lease of metathesis products.2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
Spiruchostatin A, a potent histone deacetylase inhibitor, has
been efﬁciently synthesised from (3S,4R)-4-amino-3-hydroxy-5-
methylhexanoic acid utilising solid-phase peptide elongation with
D-cysteine, D-alanine, and (E)-3-hydroxy-7-thio-4-heptenoic acid
and solution-phase macrolactonisation, followed by intramolecu-
lar disulphide formation.3
The indole nucleus of Z-Trp-OBzl has been modiﬁed by acyla-
tion of the indole nitrogen using Boc-N-methyl butyric acid fol-
lowed by catalytic hydrogenation and introduction of the Fmoc
group. The resulting derivative, Fmoc-Trp(Boc-Nmbu)-OH, has
been incorporated into peptide chains via solid-phase peptide syn-
thesis (SPPS).4
Solid-phase synthesis has been used to obtain new linear and
cyclic N,C-linked peptidocalixarenes. The synthetic strategy allows,
for the ﬁrst time, the condensation of a calix[4]arene amino acid
during the stepwise elongation sequence of the peptide. An impor-
tant role is played by the lower rim functionalisation of the calix-
arene since it modulates the ﬂexibility of the calixarene scaffold
and the conformational properties of the resulting non-natural
peptide.5
2.2. Solution-phase synthesis
A one-pot four-component reaction of an aliphatic or aromatic
amine, diketene, an aromatic aldehyde and 1,3-diphenyl-1H-pyra-zol-5-amine in the presence of p-toluenesulphonic acid as a cata-
lyst, suitable for library synthesis has been developed. In this
reaction, a new class of fully substituted pyrazolo[3,4-b]pyridine-
5-carboxamide derivatives was produced under mild reaction con-
ditions and in good yields at ambient temperature.6
2.3. Scaffolds and synthons for combinatorial libraries
No papers this month.
2.4. Solid-phase supported reagents
No papers this month.
2.5. Novel resins, linkers and techniques
A dynamic combinatorial library (DCL) based on the benzyli-
dene exchange reactions between imidazolidin-1-ol, nitrone and
oxadiazinane (INO) ring–chain–ring tautomers at room tempera-
ture has been created. The probable mechanism of the reaction is
discussed based on Hammett type correlation analyses. The effect
of Zn(II) and CF3SO3H on the DCL equilibria is also reported.7
The development of a highly efﬁcient, insoluble, and non-swell-
ing MPS-supported organocatalyst for the direct asymmetric Mi-
chael reaction of ketones and aldehydes to nitrostyrenes at room
temperature in water has been described. Excellent yields (up to
100%) and high stereoselectivities (up to 94% dr and 93% ee) were
achieved with 10 mol% of the catalyst. The resin-bound catalyst
was separated and recovered byﬁltration, and reused for six consec-
utive trials without signiﬁcant loss of activity or enantioselectivity.8
2.6. Library applications
The preparation of a library of bis-imidazolium salts and corre-
sponding palladium complexes has been reported. These com-
plexes were screened as catalysts in the Suzuki reaction between
4-bromoanisole and phenylboronic acid. Each step was performed
in parallel using a 24-position silicon carbide plate and microwave
heating. The ease and speed of operation show the potential for
microwave heating in conjunction with the silicon carbide plate
as a tool for catalyst screening.9
A library of 1,4-benzodiazepin-3-one-based turn mimetics were
synthesised and tested for their antithrombotic abilities. These
mimetics were designed to incorporate amino acid side chains of
the previously reported paratope of the inhibitory anti-von Wille-
brand Factor antibody 82D6A3. Modiﬁcations were performed on
the scaffolds by alkylation of the N1-position and acylation of the
reduced nitro group.10
A library of 3,5-disubstituted-1,2,4-oxadiazoles have been syn-
thesised and evaluated for their in vitro anti-proliferative activities
against various cancer cell lines. Formation of the 1,2,4-oxadiazole
ring was accomplished by the reaction of amidoxime with carbox-
ylic acids. The in vitro cytotoxic effects of 3,5-disubstituted-1,2,4-
oxadiazoles have been demonstrated across a wide array of tumour
cell types and a few compounds exhibited speciﬁcity towards pan-
creatic and prostate cancer cells.11
Parallel synthesis of a series of N-benzylated isatin oximes have
been developed as inhibitors of the mitogen-activated kinase,
JNK3. X-ray crystallographic structures aided in the design and
synthesis of novel, selective compounds, that inhibit JNK3, but
not p38 MAP kinase and provided key insights into understanding
the behavior of gatekeeper residue methionine-146 in determining
target selectivity for this series.12
Direct anti-tuberculosis screening of commercially available
compound libraries identiﬁed a novel piperidinol with interesting
anti-tuberculosis activity and drug like characteristics. To gener-
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optimisation library has been generated using parallel synthesis.
Products of this library 1-((R)-3-(4-chlorophenoxy)-2-hydroxy-
propyl)-4-(4-chloro-3-(triﬂuoromethyl) phenyl)piperidin-4-ol
and 1-((S)-3-(4-(triﬂuoromethyl) phenoxy)-2-hydroxypropyl)-4-
(4-chloro-3-(triﬂuoromethyl) phenyl) piperidin-4-ol demonstrated
good anti-tuberculosis activity, although side effects were observed
upon in vivo anti-tuberculosis testing of these compounds.13
Enoyl-acyl carrier protein reductase of Plasmodium falciparum
(PfENR) is an important target for antimalarial agents that interfere
with the FAS-II pathway of lipid synthesis, which is speciﬁc for the
parasite. Recent studies showed that substituted analogues of tri-
closan (TCL) inhibit the puriﬁed PfENR enzyme with IC50 values be-
low 200 nM when the suboptimal 5-chloro group was replaced by
larger hydrophobic moieties. Computer-assisted combinatorial
techniques have been used to design, focus and in silico screen a
virtual library of TCL analogues substituted at positions 5, 40 and20.14
Combinatorial biocatalysis has been applied to generate a di-
verse set of dihydroxymethylzearalenone analogues with modiﬁed
ring structure. In one representative chemoenzymatic reaction se-
quence, dihydroxymethylzearalenone was ﬁrst subjected to a un-
ique enzyme-catalyzed oxidative ring opening reaction that
creates two new carboxylic groups on the molecule. These groups
served as reaction sites for further derivatisation involving biocata-
lytic ring closure reactions with structurally diverse bifunctional
reagents, including different diols and diamines. As a result, a li-
brary of cyclic bislactones and bislactams was created, with mod-
iﬁed ring structures covering chemical space and structure activity
relationships unattainable by conventional synthetic means.15
A combined solution and solid-phase method for the synthesis
of benzodiazepinediones mimicking the lipid-modiﬁed C-terminus
of the H-Ras protein has been developed. By means of this 14-step
sequence, a collection of 42 peptidomimetics was synthesised.16
The identiﬁcation of a lead compound for fructose 1,6-bisphos-
phatase (FBPase) is a critical step in the process of developing no-
vel therapeutics against type-2 diabetes. A library of allosteric
inhibitors against FBPase have been developed as potential anti-
diabetic drugs. A thiazole-based core structure was synthesised
via the condensation of a-bromo-ketones with thioureas and sub-
stituents on the two aryl rings were varied.17
Factor VIIa (FVIIa), a serine protease, coupled with tissue factor
(TF) plays an important role in a number of thrombosis-related dis-
orders. Inhibition of TFFVIIa occurs early in the coagulation cas-
cade and might provide some safety advantages over other
related enzymes. A novel series of substituted biphenyl derivatives
that are highly potent and selective TFFVIIa inhibitors have been
investigated. Parallel synthesis coupled with structure-based drug
design allowed the exploration of the S2 pocket of the enzyme ac-
tive site, and a number of compounds with IC50 value of <10 nM
were synthesised.18
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